{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:04:21Z","timestamp":1790269461404,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:p>It is controversial whether acute myeloid leukemia (AML) patients with 20\u201329% bone marrow (BM) blasts, formerly referred to as refractory anemia with excess blasts in transformation (RAEBT), should be considered AML or myelodysplastic syndrome (MDS) for the purposes of treatment and prognostication. We retrospectively studied 571 <jats:italic>de novo<\/jats:italic> AML in patients aged <jats:styled-content>&gt;<\/jats:styled-content>50 years, including 142 RAEBT and 429 with \u226530% blasts (AML30), as well as 151 patients with 10\u201319% BM blasts (RAEB2). RAEBT patients were older and had lower white blood count, but higher hemoglobin, platelet count, and karyotype risk scores compared to AML30, while these features were similar to RAEB2. <jats:italic>FLT3<\/jats:italic> and <jats:italic>NPM1<\/jats:italic> mutations and monocytic morphology occurred more commonly in AML30 than in RAEBT. RAEBT patients were treated less often with induction therapy than AML30, whereas allogeneic stem cell transplant frequency was similar. The median and 4\u2010year OS of RAEBT patients were longer than those of AML30 patients (20.5 vs 12.0 months and 28.6% vs 20.4%, respectively, <jats:italic>P<\/jats:italic>\u2009=\u20090.003); this difference in OS was manifested in patients in the intermediate UKMRC karyotype risk group, whereas OS of RAEBT patients and AML30 patients in the adverse karyotype risk group were not significantly different. Multivariable analysis showed that RAEBT (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), hemoglobin (<jats:italic>P<\/jats:italic>\u2009=\u20090.005), UKMRC karyotype risk group (<jats:italic>P<\/jats:italic>\u2009=\u20090.002), normal BM karyotype (<jats:italic>P<\/jats:italic>\u2009=\u20090.004), treatment with induction therapy (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), and stem cell transplant (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) were associated with longer OS. Our findings favor considering <jats:italic>de novo<\/jats:italic> RAEBT as a favorable prognostic subgroup of AML. Am. J. Hematol. 89:E193\u2013E199, 2014. \u00a9 2014 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/ajh.23808","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T01:19:08Z","timestamp":1405559948000},"source":"Crossref","is-referenced-by-count":21,"title":["<i>De novo<\/i> acute myeloid leukemia with 20\u201329% blasts is less aggressive than acute myeloid leukemia with \u226530% blasts in older adults: a <scp>B<\/scp>one <scp>M<\/scp>arrow <scp>P<\/scp>athology <scp>G<\/scp>roup study"],"prefix":"10.1002","volume":"89","author":[{"given":"Robert Paul","family":"Hasserjian","sequence":"first","affiliation":[{"name":"Department of Pathology Massachusetts General Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Campigotto","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology Dana Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Klepeis","sequence":"additional","affiliation":[{"name":"Department of Pathology Massachusetts General Hospital Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bueso\u2010Ramos","sequence":"additional","affiliation":[{"name":"Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Joseph","family":"Cascio","sequence":"additional","affiliation":[{"name":"Department of Pathology Stanford University Stanford California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesun Joyce","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Pathology Cleveland Clinic Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Darryl","family":"Hsi","sequence":"additional","affiliation":[{"name":"Department of Pathology Cleveland Clinic Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Soderquist","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pennsylvania Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Pennsylvania Philadelphia Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pathology Weill Cornell Medical College  New York New Yort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Ochs","sequence":"additional","affiliation":[{"name":"Department of Pathology Weill Cornell Medical College  New York New Yort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[{"name":"Department of Pathology Weill Cornell Medical College  New York New Yort"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center Albuquerque New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center Albuquerque New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Irene","family":"George","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center Albuquerque New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Foucar","sequence":"additional","affiliation":[{"name":"Department of Pathology University of New Mexico Health Sciences Center Albuquerque New Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Odem","sequence":"additional","affiliation":[{"name":"Department of Pathology Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Booth","sequence":"additional","affiliation":[{"name":"Department of Pathology Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Morice","sequence":"additional","affiliation":[{"name":"Department of Pathology Mayo Clinic Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeAngelo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Dana Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Steensma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Dana Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Maury","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Dana Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology Dana Farber Cancer Institute Boston Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Alan","family":"Arber","sequence":"additional","affiliation":[{"name":"Department of Pathology Stanford University Stanford California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb02771.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.8.2969"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2079"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309064263"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-436055"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8329"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0354"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2008.04.013"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21723"},{"key":"e_1_2_6_13_1","first-page":"88","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Brunning RD","year":"2008"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6394"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254441"},{"key":"e_1_2_6_16_1","first-page":"124","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Arber DA","year":"2008"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000098957"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.9429"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07663.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235358"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-182782"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-283648"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(02)00220-5"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.02.018"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1309\/EM7KCQR4GLMHRCX4"},{"key":"e_1_2_6_26_1","first-page":"1596","article-title":"Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes","volume":"91","author":"Germing U","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1309\/NQ3PMV4U8YV39JWJ"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.005"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-6-32"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2013.03.022"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.23808","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.23808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T14:33:53Z","timestamp":1696602833000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.23808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1002\/ajh.23808"],"URL":"https:\/\/doi.org\/10.1002\/ajh.23808","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}